Though many cancer types showed a consistent trend of increased expression of most checkpoints with an increase in EMT score, mesenchymal Lung Adenocarcinoma (LUAD) tissues were significantly enriched in all immune checkpoint markers (except KIR3DL1) (Figure 3B). The gene discussed is KIR3DL1; the disease is lung adenocarcinoma.